InvestorsHub Logo
Followers 30
Posts 1475
Boards Moderated 0
Alias Born 07/10/2013

Re: changes_iv post# 33534

Sunday, 01/10/2021 7:18:43 AM

Sunday, January 10, 2021 7:18:43 AM

Post# of 44690
We conclude that VIP infusion reversed existing tubulointerstitial fibrosis suggesting a possible therapeutic role for a VIP based therapy in chronic kidney disease.

https://www.sciencedirect.com/science/article/pii/S0014299920300716

Tubulointerstitial renal fibrosis, characterized as a progressive detrimental connective tissue deposition on the kidney parenchyma, appears to be a harmful process leading inevitably to renal function deterioration, independently of the primary renal disease which causes the original kidney injury.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2776335/